What Q Alizer Ag does

Q Alizer AG (legal name: Q alizer AG, commercial brand: q_alizer™) is a Swiss-headquartered, privately held SaaS company that operates a cloud-based platform for orchestrating quality control (QC) and quality assurance (QA) batch release workflows in regulated industries, principally pharmaceutical and life sciences manufacturing. The product unifies data from customers' existing laboratory and enterprise systems (LIMS, ERP, MES, QMS, CDS, ELN, SDMS) into a single operational layer and exposes four integrated modules — Planning Hub, Batch Release Hub, KPI Hub, and Deviations Hub — supported by AI-driven analytics (Insight Agent, Flow Module, Sample Flow Agent) that surface bottlenecks, quantify variability via the Kingman Formula, and recommend workflow improvements. The platform is delivered on Google Cloud infrastructure with Swiss data centres and is positioned around Lean-Lab principles (WIP-driven decision making, Little's Law) inherited from the founders' prior work at Meocon and Panter.

The company sells exclusively through a direct enterprise field sales motion targeting QA and QC leaders, lab managers, planners, and lab personnel in pharmaceutical, biotech, diagnostics, food, and chemicals organizations, with a sales-led approach that includes free QC/QA data analysis trials, business case development, and ROI analysis. Revenue is generated via annual, quote-based SaaS subscriptions with unlimited user accounts and autoscaling included; no public pricing is disclosed. The go-to-market is content-driven, anchored by an insights blog on Lean principles, LinkedIn presence, an email newsletter, and downloadable business case PDFs, with demos booked through a Google Calendar appointment system.

Q Alizer is founder-owned and operated, with no disclosed institutional investors or external funding rounds. The leadership team comprises seven executives including co-founders Fabio Oro (Managing Director) and Beat Seeliger (also co-founder of Panter), plus a COO, CTO, CDO, CXO, and a CCO who additionally serves as Head of Sales since April 2025. The company was founded in 2021, is registered in the Commercial Register of Canton Zug (CHE-497.972.920), and is headquartered in Baar, Switzerland. The claimed outcomes for customers include up to 15% documentation time reduction, batch releases shortened by roughly 2 days, 2-4% annual output increases, up to 20% batch release time savings, and 3-6 month ROI, though the public website displays zero placeholder metrics for users, records, and dashboards, and no named customer logos are published.

Name

Q Alizer Ag

Legal name

Q alizer AG

Website

https://q-alizer.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

Q Alizer AG is a Swiss SaaS company that provides a cloud-based platform unifying QC and QA batch release workflows for pharmaceutical and life sciences quality organizations, integrating with existing LIMS, ERP, MES, and QMS systems and selling via direct enterprise subscriptions.

Ownership category

akta.pro rank

Product category

Pharmaceutical Quality Management Software

NAICS

Software Publishers (5132), Software Publishers (513210)

SIC

Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Business Rules Management Systems (BRMS) & Decision Automation (HDAEAHAE)

akta.pro secondary industries

Enterprise AI Data & Knowledge Platforms (Vector Databases, Knowledge Graphs) (HDAEANAH), Industry/Domain Analytics Solutions & Accelerators (BPAEAHAK)

Keywords

• Batch release management
• Pharmaceutical quality software
• QC QA analytics
• Laboratory workflow software
• Life sciences compliance

Headquarters

HQ city

Baar

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

1. SaaS Subscription: Software as a Service subscription model with cloud-based delivery on Google Cloud infrastructure. Offers unlimited user accounts included, autoscaling, and unrestricted data import/export.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Core offering

Q Alizer AG provides q_alizer™, a cloud-based SaaS platform that orchestrates QC and QA batch release workflows and lab performance for regulated life-sciences quality organizations. The platform unifies data from LIMS, ERP, MES, QMS, CDS, ELN, and SDMS into real-time dashboards, AI-powered Insight Agent analytics, and four integrated business-process hubs (Planning, Batch Release, KPI, Deviations) to replace Excel-based, reactive quality operations with proactive, Lean-driven batch release management.

Product overview

Q Alizer AG offers q_alizer™ as a unified batch release management platform for the life sciences industry. The platform consists of a core SaaS product supported by four integrated modules (hubs): Planning Hub for capacity planning and prioritization, Batch Release Hub for end-to-end batch visibility, KPI Hub for performance monitoring and benchmarking, and Deviations Hub for proactive quality management. The system unifies data from LIMS, ERP, and other enterprise sources into real-time dashboards with AI-powered analytics to transform reactive quality operations into proactive, data-driven workflows.

Differentiator

Problem solved

Functional benefit

Products and services

• q_alizer™ Batch Release Management Software for Life Sciences delivered as a cloud-based SaaS platform; helps pharmaceutical, biotech, diagnostics, food, and chemicals companies detect turbulence in the batch release process through unified data visibility across LIMS, ERP, MES, QMS, CDS, ELN, and SDMS, real-time dashboards, and AI-powered analytics.

Quantifiable outcome

• Up to 15% reduction in documentation time
• +6 more outcomes

Segments5 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability5 records

Feature9 records

Partnerships

Three partnerships are on record, tiered core and minor.

• MeoconcoreStrategic or Co-development PartnerMeocon provided the domain expertise in Lean Lab consulting that informed q_alizer's product development. Fabio Oro worked as a Lean Lab consultant at Meocon before conceiving q_alizer to make Lean Lab more efficient. Meocon contributed the pharmaceutical and quality management industry knowledge.
• PantercoreTechnology or IntegrationPanter provided technological capabilities and software architecture expertise. Dominique Schuwey previously worked as Software Architect and Senior Engineer at Panter before joining as CTO. The technological foundation of q_alizer was built by Panter's engineering team.
• 20/15 VisioneersminorStrategic or Co-development PartnerAnnounced partnership/collaboration with 20/15 Visioneers. Nature of partnership appears to be related to shared industry focus on quality management and operational excellence.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Kneat (Kneat Gx): Validation and lifecycle management platform purpose-built for GxP environments. Adjacent to q_alizer's quality/compliance workflow focus, particularly in regulated batch release documentation.
• IDBS (Danaher): Provider of scientific data management and ELN solutions for biopharma R&D and manufacturing. Overlaps with q_alizer in lab data unification and workflow visibility for regulated customers.
• Scitara: Lab integration platform enabling connectivity between lab instruments, LIMS, ELN, and informatics systems. Addresses the same data fragmentation and integration problems q_alizer targets in pharma QC labs.
• Dotmatics: Scientific R&D informatics platform (LIMS, ELN, data management) increasingly used in pharma labs. A growing player whose lab data layer could evolve into batch release analytics similar to q_alizer.
• Tulip Interfaces: Cloud-based frontline operations and quality workflow platform used in life sciences manufacturing. Competes for the same batch release process improvement and operator visibility budgets as q_alizer.

Regional players

• QbD Group: European life sciences consultancy and software provider focused on quality, validation, and GxP compliance. Regional peer with overlapping pharma quality expertise, though services-led rather than pure SaaS.

Broad incumbents

• Sartorius Stedim Biotech (Biobrain / Data Analytics): Bioprocess-focused vendor offering lab and manufacturing data analytics in life sciences. A broad incumbent with adjacent analytics capabilities that could extend into pharma QC/QA flow analytics.
• Veeva Systems: Dominant cloud software provider for life sciences with quality, regulatory, and lab offerings (Veeva Vault QMS, Vault LIMS). Competes for the same pharma QC/QA budget as q_alizer, though its scope is far broader across the enterprise.

Direct peers

• MasterControl: Provider of QMS and quality-centric software for life sciences, including batch record and deviation management. Directly overlaps q_alizer's Deviations and Batch Release Hubs in regulated pharma environments.
• LabWare: Established LIMS provider widely used in pharma QC labs. Addresses the same batch release and lab workflow challenges as q_alizer, with deeper enterprise penetration but a less specialized analytics layer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/q-alizer

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Q Alizer Ag